|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li M and Gu J: Changing patterns of
colorectal cancer in China over a period of 20 years. World J
Gastroenterol. 11:4685–4688. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rothschild BL, Shim AH, Ammer AG, Kelley
LC, Irby KB, Head JA, Chen L, Varella-Garcia M, Sacks PG, Frederick
B, et al: Cortactin overexpression regulates actin-related protein
2/3 complex activity, motility, and invasion in carcinomas with
chromosome 11q13 amplification. Cancer Res. 66:8017–8025. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schuuring E: The involvement of the
chromosome 11q13 region in human malignancies: cyclin D1 and EMS1
are two new candidate oncogenes - a review. Gene. 159:83–96. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee YY, Yu CP, Lin CK, Nieh S, Hsu KF,
Chiang H and Jin JS: Expression of survivin and cortactin in
colorectal adenocarcinoma: association with clinicopathological
parameters. Dis Markers. 26:9–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luo ML, Shen XM, Zhang Y, Wei F, Xu X, Cai
Y, Zhang X, Sun YT, Zhan QM, Wu M and Wang MR: Amplification and
overexpression of CTTN (EMS1) contribute to the metastasis of
esophageal squamous cell carcinoma by promoting cell migration and
anoikis resistance. Cancer Res. 66:11690–11699. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Timpson P, Wilson AS, Lehrbach GM,
Sutherland RL, Musgrove EA and Daly RJ: Aberrant expression of
cortactin in head and neck squamous cell carcinoma cells is
associated with enhanced cell proliferation and resistance to the
epidermal growth factor receptor inhibitor gefitinib. Cancer Res.
67:9304–9314. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Buday L and Downward J: Roles of cortactin
in tumor pathogenesis. Biochim Biophys Acta. 1775:263–273.
2007.PubMed/NCBI
|
|
9
|
Chuma M, Sakamoto M, Yasuda J, Fujii G,
Nakanishi K, Tsuchiya A, Ohta T, Asaka M and Hirohashi S:
Overexpression of cortactin is involved in motility and metastasis
of hepatocellular carcinoma. J Hepatol. 41:629–636. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Weaver AM: Cortactin in tumor
invasiveness. Cancer Lett. 265:157–166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van Rossum AG, Moolenaar WH and Schuuring
E: Cortactin affects cell migration by regulating intercellular
adhesion and cell spreading. Exp Cell Res. 312:1658–1670. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ayala I, Baldassarre M, Giacchetti G,
Caldieri G, Tetè S, Luini A and Buccione R: Multiple regulatory
inputs converge on cortactin to control invadopodia biogenesis and
extracellular matrix degradation. J Cell Sci. 121:369–378. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hashimoto Y, Akiyama Y and Yuasa Y:
Multiple-to-multiple relationships between microRNAs and target
genes in gastric cancer. PLoS One. 8:e625892013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iwaya T, Yokobori T, Nishida N, Kogo R,
Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, et
al: Down-regulation of miR-144 is associated with colorectal cancer
progression via activation of mTOR signaling pathway.
Carcinogenesis. 33:2391–2397. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang GJ, Xiao HX, Tian HP, Liu ZL, Xia SS
and Zhou T: Upregulation of microRNA-155 promotes the migration and
invasion of colorectal cancer cells through the regulation of
claudin-1 expression. Int J Mol Med. 31:1375–1380. 2013.PubMed/NCBI
|
|
17
|
Chiang Y, Song Y, Wang Z, Liu Z, Gao P,
Liang J, Zhu J, Xing C and Xu H: microRNA-192, -194 and -215 are
frequently down-regulated in colorectal cancer. Exp Ther Med.
3:560–566. 2012.PubMed/NCBI
|
|
18
|
Goel A and Boland CR: Recent insights into
the pathogenesis of colorectal cancer. Curr Opin Gastroenterol.
26:47–52. 2010. View Article : Google Scholar :
|
|
19
|
Shibuya H, Iinuma H, Shimada R, Horiuchi A
and Watanabe T: Clinicopathological and prognostic value of
microRNA-21 and microRNA-155 in colorectal cancer. Oncology.
79:313–320. 2010. View Article : Google Scholar
|
|
20
|
Althoff K, Lindner S, Odersky A, Mestdagh
P, Beckers A, Karczewski S, Molenaar JJ, Bohrer A, Knauer S,
Speleman F, et al: miR-542-3p exerts tumor suppressive functions in
neuroblastoma by downregulating Survivin. Int J Cancer.
136:1308–1320. 2015. View Article : Google Scholar
|
|
21
|
Yoon S, Choi YC, Lee S, Jeong Y, Yoon J
and Baek K: Induction of growth arrest by miR-542-3p that targets
survivin. FEBS Lett. 584:4048–4052. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Condeelis J and Segall JE: Intravital
imaging of cell movement in tumours. Nat Rev Cancer. 3:921–930.
2003. View
Article : Google Scholar
|
|
23
|
Kedrin D, Wyckoff J, Sahai E, Condeelis J
and Segall JE: Imaging tumor cell movement in vivo. Curr Protoc
Cell Biol. Chapter 19: Unit 19.7. 2007. View Article : Google Scholar
|
|
24
|
Kedrin D, van Rheenen J, Hernandez L,
Condeelis J and Segall JE: Cell motility and cytoskeletal
regulation in invasion and metastasis. J Mammary Gland Biol
Neoplasia. 12:143–152. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pollard TD, Blanchoin L and Mullins RD:
Molecular mechanisms controlling actin filament dynamics in
nonmuscle cells. Annu Rev Biophys Biomol Struct. 29:545–576. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Uruno T, Liu J, Zhang P, Fan YX, Egile C,
Li R, Mueller SC and Zhan X: Activation of Arp2/3 complex-mediated
actin polymerization by cortactin. Nat Cell Biol. 3:259–266. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hirakawa H, Shibata K and Nakayama T:
Localization of cortactin is associated with colorectal cancer
development. Int J Oncol. 35:1271–1276. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schepeler T, Reinert JT, Ostenfeld MS,
Christensen LL, Silahtaroglu, Dyrskjøt L, Wiuf C, Sørensen FJ,
Kruhøffer M, Laurberg S, et al: Diagnostic and prognostic microRNAs
in stage II colon cancer. Cancer Res. 68:6416–6424. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Slaby O, Svoboda M, Fabian P, Smerdova T,
Knoflickova D, Bednarikova M, Nenutil R and Vyzula R: Altered
expression of miR-21, miR-31, miR-143 and miR-145 is related to
clinico-pathologic features of colorectal cancer. Oncology.
72:397–402. 2007. View Article : Google Scholar
|
|
30
|
Zhang L, Liu T, Huang Y and Liu J:
microRNA-182 inhibits the proliferation and invasion of human lung
adenocarcinoma cells through its effect on human cortical
actin-associated protein. Int J Mol Med. 28:381–388.
2011.PubMed/NCBI
|
|
31
|
Hong CC, Chen PS, Chiou J, Chiu CF, Yang
CY, Hsiao M, Chang YW, Yu YH, Hung MC, Hsu NW, et al: miR326
maturation is crucial for VEGF-C-driven cortactin expression and
esophageal cancer progression. Cancer Res. 74:6280–6290. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang WT, Zhao YN, Yan JX, Weng MY, Wang Y,
Chen YQ and Hong SJ: Differentially expressed microRNAs in the
serum of cervical squamous cell carcinoma patients before and after
surgery. J Hematol Oncol. 7:62014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Y, Huang JW, Castella M, Huntsman DG
and Taniguchi T: p53 is positively regulated by miR-542-3p. Cancer
Res. 74:3218–3227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
He T, Qi F, Jia L, Wang S, Song N, Guo L,
Fu Y and Luo Y: MicroRNA-542-3p inhibits tumour angiogenesis by
targeting angiopoietin-2. J Pathol. 232:499–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shen X, Si Y, Yang Z, Wang Q, Yuan J and
Zhang X: MicroRNA-542-3p suppresses cell growth of gastric cancer
cells via targeting oncogene astrocyte-elevated gene-1. Med Oncol.
32:3612015. View Article : Google Scholar
|
